Grande Alicia's Insider Trades & SAST Disclosures
Grande Alicia's most recent trade in Catalyst Pharmaceuticals Inc was a trade of 8,666 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 27, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Grande Alicia.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 8,666 | 1,187,168 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 8,666 | 59,223 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Dec 2023 | 3,410 | 55,813 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Grande Alicia | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 60,000 | 1,195,834 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Grande Alicia | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. | 08 Dec 2023 | 60,000 | 110,557 (0%) | 0% | 1.1 | 67,800 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Grande Alicia | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. | 08 Dec 2023 | 40,000 | 90,557 (0%) | 0% | 1.1 | 45,200 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Grande Alicia | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 40,000 | 1,255,834 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Grande Alicia | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 13.74 per share. | 08 Dec 2023 | 30,000 | 80,557 (0%) | 0% | 13.7 | 412,200 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 08 Dec 2023 | 30,000 | 50,557 (0%) | 0% | 13.8 | 413,580 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 14.30 per share. | 08 Dec 2023 | 20,000 | 50,557 (0%) | 0% | 14.3 | 286,000 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 14.25 per share. | 08 Dec 2023 | 20,000 | 70,557 (0%) | 0% | 14.3 | 285,000 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share. | 28 Mar 2023 | 58,216 | 108,773 (0%) | 0% | 0.8 | 45,991 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 58,216 | 1,345,834 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. | 28 Mar 2023 | 50,000 | 100,557 (0%) | 0% | 1.1 | 56,500 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 50,000 | 1,295,834 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.60 per share. | 28 Mar 2023 | 28,216 | 80,557 (0%) | 0% | 16.6 | 468,386 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 28 Mar 2023 | 20,000 | 60,557 (0%) | 0% | 16.7 | 334,000 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.72 per share. | 28 Mar 2023 | 20,000 | 80,557 (0%) | 0% | 16.7 | 334,400 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.37 per share. | 28 Mar 2023 | 10,000 | 50,557 (0%) | 0% | 16.4 | 163,700 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 28 Mar 2023 | 10,000 | 60,557 (0%) | 0% | 16.5 | 165,200 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.55 per share. | 28 Mar 2023 | 10,000 | 70,557 (0%) | 0% | 16.6 | 165,500 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.67 per share. | 28 Mar 2023 | 10,000 | 50,557 (0%) | 0% | 16.7 | 166,700 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share. | 22 Mar 2023 | 38,524 | 89,081 (0%) | 0% | 0.8 | 30,434 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.51 per share. | 22 Mar 2023 | 38,524 | 50,557 (0%) | 0% | 16.5 | 636,031 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2023 | 38,524 | 1,404,050 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share. | 22 Mar 2023 | 3,260 | 53,817 (0%) | 0% | 0.8 | 2,575 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.41 per share. | 22 Mar 2023 | 3,260 | 50,557 (0%) | 0% | 16.4 | 53,497 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2023 | 3,260 | 1,442,574 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 11,166 | 1,445,834 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 11,166 | 53,275 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Feb 2023 | 2,718 | 50,557 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 88,000 | 1,431,000 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 26,000 | 1,457,000 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 14,667 | 42,109 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 14,667 | 1,343,000 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 16.53 per share. | 22 Nov 2022 | 120,000 | 27,442 (0%) | 0% | 16.5 | 1,983,240 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 15.77 per share. | 15 Nov 2022 | 60,000 | 147,442 (0%) | 0% | 15.8 | 946,080 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 11.90 per share. | 23 Sep 2022 | 60,000 | 207,442 (0%) | 0% | 11.9 | 713,940 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 16 Sep 2022 | 90,000 | 267,442 (0%) | 0% | 13.5 | 1,214,640 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 15.57 per share. | 14 Sep 2022 | 50,000 | 357,442 (0%) | 0% | 15.6 | 778,650 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 26 Aug 2022 | 20,000 | 444,442 (0%) | 0% | 14.1 | 282,800 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 26 Aug 2022 | 20,000 | 424,442 (0%) | 0% | 14.2 | 284,000 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 14.28 per share. | 26 Aug 2022 | 17,000 | 407,442 (0%) | 0% | 14.3 | 242,760 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 14.40 per share. | 26 Aug 2022 | 11,095 | 464,442 (0%) | 0% | 14.4 | 159,768 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 99,316 | 1,408,351 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 13.85 per share. | 17 Aug 2022 | 99,316 | 475,537 (0%) | 0% | 13.9 | 1,375,745 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 17 Aug 2022 | 99,316 | 574,853 (0%) | 0% | 2.5 | 251,269 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 17 Aug 2022 | 31,425 | 506,962 (0%) | 0% | 2.5 | 79,505 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 13.87 per share. | 17 Aug 2022 | 31,425 | 475,537 (0%) | 0% | 13.9 | 435,890 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 31,425 | 1,376,926 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 19,259 | 1,357,667 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 17 Aug 2022 | 19,259 | 494,796 (0%) | 0% | 2.5 | 48,725 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 13.70 per share. | 17 Aug 2022 | 19,259 | 475,537 (0%) | 0% | 13.7 | 263,848 | Common Stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 33,500 | 1,507,667 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2021 | 167,500 | 1,474,167 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2021 | 14,667 | 1,306,667 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2021 | 14,667 | 479,108 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Dec 2021 | 3,571 | 475,537 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 100,000 | 1,391,334 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 5.67 per share. | 17 Aug 2021 | 100,000 | 407,441 (0%) | 0% | 5.7 | 566,900 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 17 Aug 2021 | 100,000 | 507,441 (0%) | 0% | 3.1 | 312,000 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 70,000 | 1,321,334 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 17 Aug 2021 | 70,000 | 477,441 (0%) | 0% | 3.1 | 218,400 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Sale of securities on an exchange or to another person at price $ 5.68 per share. | 17 Aug 2021 | 13,000 | 464,441 (0%) | 0% | 5.7 | 73,879 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2020 | 14,666 | 411,012 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2020 | 14,666 | 1,241,334 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Alicia Grande | VP, Treasurer and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 22 Dec 2020 | 3,571 | 407,441 (0%) | 0% | - | Common Stock, par value $0.001 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges